Trump's trade threats and tariffs target various countries and industries, sparking fears of a global trade war.
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway ...
Total Revenues of $491.7 Million, Marking Another Year of Record GrowthFull Year 2024 Total Revenues Grew 23.5% YoY, Driven by ...
A case study on how one of the leading pharma companies in the oncology space approached DelveInsight with a pressing need for conference coverage to monitor the activities and data readouts of ...
The global ankylosing spondylitis treatment market is experiencing steady growth, driven by advancements in therapeutic ...